Company intelligence / Profile preview

Bell & Holmes

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Bell & Holmes is a global primary research consultancy founded in 2021 that specializes in conducting B2B interviews for commercial due diligence, market sizing, and strategic insight projects across all industries—including but not limited to healthcare—serving primarily private equity firms and major consulting companies. It does not develop drugs or medical technologies nor operate as a biotech/pharma/CRO/CMO company[1][2].

Industry: Consulting

Partnerships

Big Three consultanciesBig Four accounting firmsPrivate equity funds

Beyond the preview

Go deeper on Bell & Holmes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bell & Holmes.

Explore the full profile